Skip to main content
BALCHEM CORP logo

BALCHEM CORP — Investor Relations & Filings

Ticker · BCPC ISIN · US0576652004 LEI · 549300VR70OPMHUI3557 US Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2006-05-02 Regulatory Filings
Country US United States of America
Listing US BCPC

About BALCHEM CORP

https://balchem.com/

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. The company operates through three primary segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health division is a leader in essential nutrients like choline, chelated minerals, and vitamin K2, utilizing advanced microencapsulation technologies for the food and nutritional supplement markets. The Animal Nutrition & Health segment provides a portfolio of products to meet the nutritional needs of animals, with a key position in choline chloride. The Specialty Products segment includes Performance Gases for various industrial applications and Plant Nutrition solutions. Balchem is focused on delivering innovative, science-based solutions to improve health and nutrition.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2006
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A filed with the SEC, which is an amendment to a previously filed Form 8-K. It provides detailed financial statements and pro forma financial information related to the acquisition of Chelated Minerals Corporation by Balchem Corporation. The document includes audited financial statements, auditor's report, consolidated balance sheet, statement of operations, cash flows, and notes to the financial statements. The presence of detailed financial data and the context of acquisition-related financial disclosures indicate this is a regulatory filing providing financial information about an acquisition, not a full annual or quarterly report. Form 8-K filings with financial statements related to acquisitions are typically classified under Regulatory Filings (RNS) as they are current reports disclosing material events rather than comprehensive annual or interim reports. The document is lengthy (15,000 characters) and contains substantive financial data, so it is not a mere announcement or certification. Therefore, the appropriate classification is Regulatory Filings (RNS).
2006-05-02 English
Proxy Solicitation & Information Statement 2006
Proxy Solicitation & Information Statement
2006-04-28 English
Director's Dealing 2006
Director's Dealing
2006-04-03 English
Director's Dealing 2006
Director's Dealing
2006-03-31 English
Director's Dealing 2006
Director's Dealing
2006-03-29 English
Director's Dealing 2006
Director's Dealing
2006-03-28 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.